Exchange: NYSEMkt·Updated 07:45 PM EST

About AEON

About

AEON Biopharma, Inc. is a biopharmaceutical company, which engages in the business of developing proprietary botulinum toxin complex, ABP-450 injection, for debilitating medical conditions. The company was founded by Robert E. Grant on February 24, 2012 and is headquartered in Irvine, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
8

Frequently Asked Questions

Advertisement|Remove ads.